Caris Life Sciences, Inc. (CAI)
NASDAQ·Healthcare·Biotechnology
$16.41
+4.79%
Mkt Cap $4.42B
Analyst Ratings
Buy
9
Hold
1
Sell
0
Price Target (10 analysts)
$25.00
Range $21.00 – $32.00
Implied Upside
+52.4%
Consensus $25.00 vs current $16.41
NASDAQ·Healthcare·Biotechnology
$16.41
+4.79%
Mkt Cap $4.42B
Buy
9
Hold
1
Sell
0
Price Target (10 analysts)
$25.00
Range $21.00 – $32.00
+52.4%
Consensus $25.00 vs current $16.41